Lindsay Bengtson, PhD, MPH

Associate Director 

Respiratory Disease


Dr. Lindsay Bengtson joined Optum in 2015 and holds a PhD and an MPH in epidemiology from the University of Minnesota. She has over 80 peer-reviewed publications and conference presentations focused on respiratory, cardiovascular and infectious diseases.  

Published work 

Chen LY, Norby FL, Chamberlain AM, MacLehose RF, Bengtson LG, Lutsey PL, Alonso A. CHA2DS2-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and Hispanics. Stroke. 2018;50:28–33.

Bengtson LGS, DePietro M, McPheeters J, Fox KM. Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy. Ther Adv Respir Dis. 2018;12:1753466618772750.

Bengtson LGS, Yu Y, Wang W, Cao F, Hulbert EM, Wolbeck R, Elliott CA, Buikema AR. Inhaled corticosteroid-containing treatment escalation and outcomes for patients with asthma in a U.S. health care organization. J Manag Care Spec Pharm. 2017 Nov;23(11):1149-1159.

Rosenblatt L, Buikema AR, Seare J, Bengtson LG, et al. Economic outcomes of first-line regimen switching among stable patients with HIV. J Manag Care Spec Pharm. 2017;23(7):725-734.

Bengtson LG, McPheeters JT, Fang Y, Cao F, Elliott C, Fox KM, Buikema AR, DePietro M. Impact of chronic obstructive pulmonary disease (COPD) coding differences on health care utilization and cost outcomes for research spanning the ICD-9 to ICD-10 transition. Paper presented at: ISPOR 22nd Annual International Meeting; 2017 May 20-24; Boston, MA. 


HEOR, Health Economics Outcomes Research, Health Economics, Respiratory Disease, Infectious Disease